Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II).

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 6681533)

Published in Cancer Res on February 01, 1983

Authors

D J Stewart, R S Benjamin, S Zimmerman, R M Caprioli, S Wallace, V Chuang, D Calvo, M Samuels, J Bonura, T L Loo

Articles citing this

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article. J Neurosurg (2010) 1.15

Intraarterial chemotherapy for extremity osteosarcoma and MFH in adults. Clin Orthop Relat Res (2008) 1.01

Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study. Neurosurgery (2010) 0.89

Impact of low and high tidal volumes on the rat alveolar epithelial type II cell proteome. Am J Respir Crit Care Med (2007) 0.87

A new method for repeated drug infusion into the femoral artery of mice. J Am Assoc Lab Anim Sci (2012) 0.82

Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck. Br J Clin Pharmacol (1991) 0.81

Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model. J Exp Clin Cancer Res (2016) 0.76

A phase II study of the efficacy of diamminedichloroplatinum (cisplatin) for the control of locally recurrent and intransit malignant melanoma of the extremities using tourniquet outflow-occlusion techniques. Ann Surg (1989) 0.75

The negative-balance isolated pelvic perfusion method using ultrahigh-dose cisplatin for invasive bladder cancer with poor risk. Int J Clin Oncol (2010) 0.75

Articles by these authors

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54

Developing and implementing clinical practice guidelines. Qual Health Care (1995) 6.52

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med (1993) 4.91

Separation and characterization of factors mediating accurate transcription by RNA polymerase II. J Biol Chem (1982) 4.71

Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med (2001) 4.26

In vitro transcription: whole-cell extract. Methods Enzymol (1983) 4.07

Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol (1999) 3.48

Interactions between RNA polymerase II, factors, and template leading to accurate transcription. J Biol Chem (1984) 3.47

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet (2000) 3.39

The Atf1 transcription factor is a target for the Sty1 stress-activated MAP kinase pathway in fission yeast. Genes Dev (1996) 3.36

Regulation of the fission yeast transcription factor Pap1 by oxidative stress: requirement for the nuclear export factor Crm1 (Exportin) and the stress-activated MAP kinase Sty1/Spc1. Genes Dev (1998) 3.27

A sperm cytoskeletal protein that signals oocyte meiotic maturation and ovulation. Science (2001) 3.26

Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg (1966) 3.00

Plasma concentrations after oral or intramuscular vitamin K1 in neonates. Arch Dis Child (1985) 2.69

The effects of enalapril on hypertension and quality of life. A large multicenter study in Belgium. Acta Cardiol (1989) 2.66

5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J Biol Chem (1989) 2.65

Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer (1990) 2.56

Affecting the supply of rural physicians. Am J Public Health (1977) 2.51

Amino acid sequence of pilin from Bacteroides nodosus (strain 198), the causative organism of ovine footrot. FEBS Lett (1983) 2.35

Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate. J Clin Oncol (1983) 2.35

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32

Control of asthma in Canada: failure to achieve guideline targets. Can Respir J (2001) 2.26

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22

A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut (2002) 2.22

The urease activity of fluorescent pseudomonads. J Gen Microbiol (1965) 2.17

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer (1974) 2.10

Changes in the helical repeat of poly(dG-m5dC) . poly(dG-m5dC) and poly(dG-dC) . poly(dG-dC) associated with the B-Z transition. Nature (1981) 2.06

Inappropriate sensor application in pulse oximetry. Lancet (1992) 2.06

Endothelin receptor blockade improves endothelial function in human internal mammary arteries. Cardiovasc Res (2001) 2.02

Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res (2001) 1.95

Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer (2001) 1.89

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85

DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells. Proc Natl Acad Sci U S A (2000) 1.82

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol (2012) 1.81

Polyclonal and monoclonal antibody and PCR-amplified small-subunit rRNA identification of a microsporidian, Encephalitozoon hellem, isolated from an AIDS patient with disseminated infection. J Clin Microbiol (1994) 1.80

Micro-electrospray mass spectrometry: Ultra-high-sensitivity analysis of peptides and proteins. J Am Soc Mass Spectrom (1994) 1.79

LATCH: a breastfeeding charting system and documentation tool. J Obstet Gynecol Neonatal Nurs (1994) 1.79

Peritoneal lavage in appendicular peritonitis. Br J Surg (1978) 1.78

Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation (2000) 1.75

Stimulation of p300-mediated transcription by the kinase MEKK1. J Biol Chem (2001) 1.72

Mechanical devices for arterial occlusion. Am J Roentgenol Radium Ther Nucl Med (1975) 1.72

Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum (2004) 1.71

Expression of pili from Bacteroides nodosus in Pseudomonas aeruginosa. J Bacteriol (1986) 1.70

Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology (1981) 1.70

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65

An epilepsy needs document. Seizure (1993) 1.64

The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients. AJR Am J Roentgenol (1991) 1.63

Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J Clin Oncol (1992) 1.61

Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension. Am J Respir Cell Mol Biol (1999) 1.60

A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res (2001) 1.59

Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg (1990) 1.59

Purification and characterization of a specific RNA polymerase II transcription factor. J Biol Chem (1986) 1.58

Cooperation of structural proteins during late events in the life cycle of polyomavirus. J Virol (1993) 1.58

Cloning DNA sequences from influenza viral RNA segments. Proc Natl Acad Sci U S A (1980) 1.54

A new and improved "quick-hot Gram-chromotrope" technique that differentially stains microsporidian spores in clinical samples, including paraffin-embedded tissue sections. Arch Pathol Lab Med (1997) 1.53

Simultaneous analysis of ATP, ADP, AMP, and other purines in human erythrocytes by high-performance liquid chromatography. J Chromatogr (1980) 1.52

Inhibition of transcription factor activity by poliovirus. Cell (1981) 1.51

Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res (1998) 1.51

Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg (1986) 1.50

Direct profiling of proteins in biological tissue sections by MALDI mass spectrometry. Anal Chem (1999) 1.48

Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev (2001) 1.48

Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47

Selective inhibition of in vitro DNA synthesis dependent on phiX174 compared with fd DNA. I. Protein requirements for selective inhibition. J Biol Chem (1977) 1.47

Vascular dysfunction after repair of coarctation of the aorta: impact of early surgery. Circulation (2001) 1.47

Adriamycin cardiomyopathy--risk factors. Cancer (1977) 1.46

Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45

Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45

Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45

Thymine ring saturation and fragmentation products: lesion bypass, misinsertion and implications for mutagenesis. Mutat Res (1993) 1.44

A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study Group. Ann Oncol (1996) 1.44

Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage renal disease. Cochrane Database Syst Rev (2001) 1.44

Gliomatosis cerebri in a 10-year-old girl masquerading as diffuse encephalomyelitis and spinal cord tumour. Dev Med Child Neurol (2001) 1.43

Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol (2010) 1.42

Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet (1993) 1.42

Transcatheter occlusion of abdominal tumors. Radiology (1976) 1.41

Prevalence of tetracyclines in children's teeth. II. A resurvey after five years. Br Med J (1973) 1.41

Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study. J Natl Cancer Inst (1991) 1.40

The structure of helical 5'-guanosine monophosphate. J Mol Biol (1975) 1.40

Primary hepatic lymphoma in a patient with chronic hepatitis C. J Gastroenterol Hepatol (1994) 1.39

Fine needle aspiration of palpable breast lumps: a 1-year audit using the Cytospin method. Cytopathology (1992) 1.39

Chemotherapy and embolization via the inferior epigastric artery for the treatment of primary and metastatic cancer. AJR Am J Roentgenol (1989) 1.39

Generalized lymphadenopathy due to herpes simplex virus type I. Histopathology (1991) 1.38

An unusual Donath-Landsteiner antibody detectable at 37 degrees C by the antiglobulin test. Transfusion (1985) 1.38

Diagnosis of recurrent suffocation of children. Lancet (1992) 1.37

Combination chemotherapy in adult desmoid tumors. Cancer (1993) 1.36

Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res (1977) 1.36

Action of colcemid in sea urchin eggs. J Cell Biol (1967) 1.36

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol (1997) 1.34

Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation (2001) 1.34

Reproducibility and complications in gene searches: linkage on chromosome 6, heterogeneity, association, and maternal inheritance in juvenile myoclonic epilepsy. Am J Hum Genet (2000) 1.34

Tetracyclines: their prevalence in children's teeth. Br Dent J (1968) 1.33

Rural or urban practice: factors influencing the location decision of primary care physicians. Inquiry (1975) 1.32

Overview--flavonoids: a new family of benzodiazepine receptor ligands. Neurochem Res (1997) 1.32

Neuroactive flavonoids: new ligands for the Benzodiazepine receptors. Phytomedicine (1998) 1.32

Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother (1979) 1.31

Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet (1999) 1.31

Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor. Cancer Chemother Pharmacol (2000) 1.31

Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer (1999) 1.31